2014 Honda Cr-v Ex on 2040-cars

Auto blog

Honda Ridgeline, Ford Ecosport and Tesla profits | Autoblog Podcast #537

On this week's Autoblog Podcast, Editor-in-Chief Greg Migliore is joined by Green Editor John Beltz Snyder and Associate Editor Joel Stocksdale. We talk about driving the 2018 Ford Ecosport and Hyundai Accent. Joel tells us why he loves the naturally aspirated engine in our long-term Honda Ridgeline. We discuss Tesla's profitability claims, Johan de Nysschen leaving Cadillac and a possible date change for the Detroit Auto Show. As usual, we'll also spend a listener's money on a car. Autoblog Podcast #537 Get The Podcast iTunes – Subscribe to the Autoblog Podcast in iTunes RSS – Add the Autoblog Podcast feed to your RSS aggregator MP3 – Download the MP3 directly Rundown Driving the 2018 Ford Ecosport Driving the 2018 Hyundai Accent A love letter to the Honda Ridgeline's V6 Leadership change at Cadillac Will Tesla be profitable this year? Will NAIAS move to October? Spend my money Feedback Email – Podcast@Autoblog.com Review the show on iTunes Related Video: Earnings/Financials Green Podcasts Detroit Auto Show Cadillac Ford Honda Hyundai Tesla Used Car Buying Truck Crossover SUV Economy Cars Electric Sedan

Honda renews trademark for Acura CDX compact crossover

Honda recently renewed its U.S. trademark for the name "CDX," which the Japanese carmaker first applied for in 2015. Back then, observers expected the name to apply to an Acura version of the Honda HR-V, and they were right — but no one expected the CDX would go on sale only in China, in 2016. For the past two years, the U.S. auto media has speculated on whether the CDX will ever make it here. "(We) have our R&D guys looking into the possibility," group VP of Acura U.S. Jon Ikeda told Wards Auto last April about the CDX. However, he went on to note that it's not as simple as just shipping it over due to regulation differences between China and the United States. The trademark application doesn't mean a green light, but it shows Honda's at least leaving the door open to the prospect. The Chinese-market CDX is a Honda HR-V after a wardrobe change. The only engine option is the 1.5-liter turbocharged four-cylinder from the Civic, CR-V, and Accord, with 179 horsepower and 177 pound-feet (our HR-V uses a 1.8-liter four-cylinder with 141 hp and 127 lb-ft). The only transmission offered is an eight-speed dual-clutch gearbox. Drivetrains can be had in front- or all-wheel drive. We wonder how much longer Honda can sit on the sidelines. The CDX doubled Acura's sales in China in one year. Acura sells more crossovers than sedans in the United States, and in the past two years that the CDX has been on sale in China, the compact crossover segment here has got more crowded and more popular. The Cadillac XT4 is imminent, and we could see the new Lexus UX compact crossover at the Geneva Motor Show. Really, an American-market Acura CDX can't come soon enough. Related Video: News Source: Bozi Tatarevic via Autoevolution Auto News Government/Legal Rumormill Acura Honda Crossover Luxury honda hr-v

2013 Honda Civic

Lather, Rinse, Repeat
On some level, it's hard to blame Honda for the strategy it took with its new-for-2012 Civic. Executives looked at the key players on the market as the model was being developed, soaked in the growing global economic malaise, and decided that if they wanted to make decent money on their small car, they'd have to find creative ways to take cost out of its build. In light of the financial crisis, consumers and critics would surely understand some belt-tightening in order to secure the company's legendary reliability, resale value and ease-of-use, right?
So Honda took a pass on expensive new technology - more complex transmissions, forced induction, active aero, and so on. And it also substituted in some cheaper interior materials, skimped on sound deadening, creature comforts and found lots of little ways to save money. Surely in a segment where the frankly ancient and moth-eaten Toyota Corolla has consistently ranked among the sales leaders, nobody would care, eh?